PROCEPT BioRobotics Corporation (“PROCEPT” or “the Company”) is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). BPH, the non-malignant enlargement of the prostate gland, is the most common prostate disease and impacts ~40M men in the United States.